These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 806754)

  • 21. A comparison of the susceptibilities of anaerobic bacteria to trimethoprim and sulfamethoxazole individually and in combination.
    Tosolini FA; Butcher RH
    Clin Ther; 1983; 5(6):629-31. PubMed ID: 6605193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The invitro activity of teicoplanin and vancomycin against gram positive microorganisms (corrected)].
    Kayaokay Y; Hasçelik G; Gür D; Akalin E
    Mikrobiyol Bul; 1991 Oct; 25(4):321-5. PubMed ID: 1839050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibacterial action of trimethoprim-sulfamethoxazole.
    Gallien R
    J Infect Dis; 1973 Nov; 128():Suppl:486-97 p. PubMed ID: 4202206
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evolution from 1976 to 1986 of bacterial prevalence and sensitivity to urinary antibiotics of bacteria isolated from urine cultures at a city microbiology laboratory].
    Chouteau J
    Pathol Biol (Paris); 1988 May; 36(5):439-41. PubMed ID: 3136425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antibacterial activity of co-trimoxazole and tetroxoprim/sulfadiazine in vitro (author's transl)].
    Hahn H; Kirov A
    Arzneimittelforschung; 1980; 30(7):1047-8. PubMed ID: 7191284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Present significance of resistance to trimethoprim and sulphonamides in coliforms, Staphylococcus aureus, and Streptococcus faecalis.
    Lewis EL; Lacey RW
    J Clin Pathol; 1973 Mar; 26(3):175-80. PubMed ID: 4633678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of in vitro antibacterial activities of the combination of trimethoprim and sulfamethoxazole on clinical isolates in Japan.
    J Infect Dis; 1973 Nov; 128():Suppl:502-7 p. PubMed ID: 4585955
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antibacterial activity of the combination trimethoprim-sulfamethoxazole compared with antibiotics].
    Böhni E
    Schweiz Med Wochenschr; 1969 Oct; 99(42):1505-10. PubMed ID: 4903288
    [No Abstract]   [Full Text] [Related]  

  • 29. [In vitro studies on the antibacterial effect of gentamicin].
    Auwärter W; Naumann P
    Arzneimittelforschung; 1968 Sep; 18(9):1115-9. PubMed ID: 4974677
    [No Abstract]   [Full Text] [Related]  

  • 30. Susceptibility of obligate anaerobes to trimethoprim-sulfamethoxazole.
    Indiveri MC; Hirsh DC
    J Am Vet Med Assoc; 1986 Jan; 188(1):46-8. PubMed ID: 3484737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility of Staphylococcus aureus to sulphametoxazol-trimethoprim (author's transl).
    Herrera R; Sanles C
    Rev Med Chil; 1974 Dec; 102(12):927-30. PubMed ID: 4463435
    [No Abstract]   [Full Text] [Related]  

  • 32. [The resistance of urinary tract bacteria in hospital environment over a 4-year period. A prospective study with special reference to trimethoprim, sulfonamide and a combination of them].
    Busk HE; Korner B; Hammer R
    Ugeskr Laeger; 1985 Nov; 147(48):3895-7. PubMed ID: 3878615
    [No Abstract]   [Full Text] [Related]  

  • 33. [Studies on the antibacterial activity of the combination sulfamoxole/trimethoprim (CN 3123) (author's transl)].
    Legler F
    Arzneimittelforschung; 1976; 26(42):658-61. PubMed ID: 947327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Letter: Trimethoprim-sulfamethoxazole: in vitro sensitivity of 1000 clinical isolates.
    Amies CR
    Can Med Assoc J; 1974 Jun; 110(12):1336-7. PubMed ID: 4834522
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antimicrobial action of the combined preparation sulfamoxole/trimethoprim in vitro (author's transl)].
    Kohlmann FW; Sous H
    Arzneimittelforschung; 1976; 26(42):613-8. PubMed ID: 947321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antibacterial activity in vitro and in vivo of the trimethoprim-sulphamethoxazole combination].
    Renzini G; Ravagnan G; Bormioli P; D'Alessandro A
    Antibiotica; 1969 Dec; 7(4):250-68. PubMed ID: 5004706
    [No Abstract]   [Full Text] [Related]  

  • 37. Resistance pattern and species distribution of strains isolated from patients with catheters in central veins.
    Brandberg A; Lindblom GB; Norrby R; Alestig K
    Scand J Infect Dis Suppl; 1976; (8):56-7. PubMed ID: 1064914
    [No Abstract]   [Full Text] [Related]  

  • 38. [In vitro antibacterial effect of sulfamoxole/trimethoprim and sulfamethoxazole/trimethoprim].
    Hingst V; Sonntag HG
    Med Welt; 1979 Aug; 30(33):1199-201. PubMed ID: 491915
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of biseptol for preventing the development of rifampicin-resistant Mycobacterium tuberculosis].
    Dolzhanskiĭ VM
    Probl Tuberk; 1988; (4):54-6. PubMed ID: 3138686
    [No Abstract]   [Full Text] [Related]  

  • 40. Sensitivity of Streptococcus pyogenes to sulphamethoxazole, trimethoprim, and cotrimoxazole.
    Yourassowsky E; Vanderlinden MP; Schoutens E
    J Clin Pathol; 1974 Nov; 27(11):897-901. PubMed ID: 4613734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.